Login to Your Account


Pharma: Other News To Note


Friday, June 22, 2012
• Teva Pharmaceutical Industries Ltd., of Jerusalem, launched its generic equivalent of Symbyax (olanzapine and fluoxetine, Eli Lilly and Co.) in the U.S.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription


»

For Sales Inquiries,
http://clarivate.com/life-sciences/news/bioworld/#

 
Privacy Policy | Terms of Use | Copyright
 
Note: our contact information has changed
Customer Care: http://support.clarivate.com
© 2018 Clarivate Analytics.
Reproduction, reposting content is strictly prohibited.
Clarivate Analytics